Technical outcome – Health IT can create an electronic antimicrobial use and resistance report for the following three sections of the HL7® Implementation Guide for CDA® Release 2 – Level 3: Healthcare Associated Infection (HAI) Reports, Release 1, U.S. Realm, August 2013:
- HAI Antimicrobial Use and Resistance (AUR) Antimicrobial Resistance Option (ARO) Report (Numerator) specific document template in Section 2.1.2.1 (pages 69-72);
- Antimicrobial Resistance Option (ARO) Summary Report (Denominator) specific document template in Section 2.1.1.1 (pages 54-56); and
- Antimicrobial Use (AUP) Summary Report (Numerator and Denominator) specific document template in Section 2.1.1.2 (pages 56-58).
Clarifications:
- For the public health certification criteria in § 170.315(f), health IT will only need to be certified to those criteria that are required to meet the measures the provider intends to report on to meet Objective 8: Public Health and Clinical Data Registry Reporting.
- The antimicrobial use and resistance reporting information for electronic transmission will be collected by the Centers for Disease Control and Prevention (CDC) only rather than at the jurisdictional level. [see also 80 FR 62668]
- Health IT developers choosing to exercise the Standards Version Advancement Process (SVAP) for this criterion should use the following guidance for measures described at 170.205(r)(1):
- For (i) “HAI Antimicrobial Use and Resistance (AUR) Antimicrobial Resistance Option (ARO) Report (Numerator)...”:
- Use the SVAP-approved standard “HL7® CDA® R2 Implementation Guide: Healthcare Associated Infection (HAI) Reports, Release 3 - US Realm, December 2020
- For (ii) “Antimicrobial Resistance Option (ARO) Summary Report (Denominator)…":
- Use the SVAP-approved standard “HL7® CDA® R2 Implementation Guide: Healthcare Associated Infection (HAI) Reports, Release 3 - US Realm, December 2020”
- For (iii) “Antimicrobial Use (AUP) Summary Report (Numerator and Denominator)”:
- Continue to use the base standard adopted at 170.205(r)(1) “Health Level 7 (HL7®) Implementation Guide for CDA® Release 2 – Level 3: Healthcare Associated Infection (HAI) Reports, Release 1, U.S. Realm, August 2013”
- For (i) “HAI Antimicrobial Use and Resistance (AUR) Antimicrobial Resistance Option (ARO) Report (Numerator)...”:
- For support with the testing and/or test tool for this criterion, please contact CDC at NHSNCDA@cdc.gov.
